Lifitegrast

Trade Name: 
Xiidra
Manufacturer/Distributor: 
Shire Pharma Canada
Classification: 
Lymphocyte function associated antigen-1 (LFA-1) antagonist
Miscellaneous anti-inflammatory agent
ATC Class: 
S01XA25 - lifitegrast
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2017/12/22
Date Marketed in Canada (yyyy/mm/dd): 
2017/12/22
Presentation: 
Ophthalmic drops: 5%. DIN: 02471027
Comments: 
For treatment of dry eye disease.